Gilead (GILD) Announced Interim Phase 2 Data on Hepatitis Drugs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CRWV
2. SMCI
3. GAMI
4. LITE
5. ONON
6. SPY
7. CAVA
8. CSCO
9. USO

Go back to Gilead (GILD) Announced Interim Phase 2 Data on Hepatitis Drugs
Gilead Sciences (NASDAQ: GILD) Delayed: 135.87 +0.10 (0.07%)
Previous Close $135.77    52 Week High $108.63 
Open $133.99    52 Week Low $71.39 
Day High $137.12    P/E 75.07 
Day Low $133.30    EPS $1.81 
Volume 5,684,004